Publication

Organometallic ruthenium-based antitumor compounds with novel modes of action

Related publications (77)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Organometallic ruthenium-based antitumor compounds with novel modes of action

Graph Chatbot

Chat with Graph Search

Multidimensional Texture Analysis for Improved Prediction of Ultrasound Liver Tumor Response to Chemotherapy Treatment

Development of mass spectrometric methods to understand the mechanism of action of transition metal-based anticancer compounds

Guidelines for Measurement of Luminescence Spectra and Quantum Yields of Inorganic Compounds, Metal Complexes, and Materials

Photoactivation of lysosomally sequestered sunitinib after angiostatic treatment causes vascular occlusion and enhances tumor growth inhibition

Engineering opportunities in cancer immunotherapy

Fluorescence lifetime imaging to differentiate bound from unbound ICG-cRGD both in vitro and in vivo

Thermoresponsive fluorinated small-molecule drugs: a new concept for efficient localized chemotherapy

Rational design of organic and organometallic thermoresponsive or tumor-selective anticancer drugs and their in vitro and in vivo biological evaluation

GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer

Investigating the Optimal Size of Anticancer Nanomedicine